HistoIndex

HistoIndex AI Analysis Confirms Strong Fibrosis Improvement in D&D Pharmatech's Phase 2 MASH Trial This month, HistoIndex announced new data highlighting the value of AI-powered quantitative pathology in advancing MASH drug development. Using our propriet

AI-Powered Analysis by HistoIndex Reveals Robust Liver Fibrosis Improvement with D&D Pharmatech's Zabopegdutide in Phase 2 MASH Trial SINGAPORE and SEOUL, South Korea, June 17, 2026 /PRNewswire/ - HistoIndex, a leader in AI-powered digital pathology solut

Clinical Spotlight is a HistoIndex newsletter series that explores topics in MASH, clinical diagnostics, and chronic liver disease management. Each edition provides commentary based on evidence from relevant publications and the latest research developmen

April Highlights Driving Momentum Through New Strategic Partnerships in Texas and California The past month, we continued to build momentum, expanding access to advanced quantitative diagnostics across the U.S. through new partnerships with Houston Resear

SINGAPORE, April 28, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnership network in the United States with the addition of two n

HistoIndex Extends Access To Its MASH Diagnostic Offering Through New Partnerships In Texas And California SINGAPORE, April 28, 2026 /PRNewswire/ - HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the

March Highlights qFibrosis Revealing New Insights into Treatment Response with Resmetirom in the MAESTRO-NASH Phase 3 Study qFibrosis once again takes center stage in advancing our understanding of fibrosis in MASH. A recent Journal of Hepatology publicat

As Metabolic Dysfunction-associated Steatohepatitis (MASH) continues to rise in both clinical prevalence and therapeutic focus, the demand for accurate, reproducible, and scalable fibrosis assessment has intensified. Fibrosis remains the most critical his

February Highlights qFibrosis Uncovers Divergent Collagen Remodeling Across Liver Disease Subtypes A recent study conducted by Seoul National University Boramae Medical Center and Kyung Hee University Hospital provides new insights into fibrosis progressi

Advancing MASH Diagnostics Through Strategic Partnerships January 20, 2026 - HistoIndex is set to expand its footprint in clinical hepatology and gastroenterology through new commercial partnerships with leading medical centers in the US and Europe. These